The specific aims of the Laboratory Cancer Research Center at the Eppley Institute for Research in Cancer and Allied Diseases are to carry out interdisciplinary research in: 1) cancer cause and prevention aimed at determining the mechanisms of action of chemical carcinogens, including the mechanisms of activation of carcinogens and their interactions with DNA, the role of potential environmental carcinogens in human cancer, the interaction of oncogenes and chemical carcinogens in tumor initiation and promotion, and the role of dietary factors in causing and preventing cancer; 2) molecular and cellular biology , including DNA replication, mechanisms of gene transcription, the mechanisms of action of growth factors and hormones, characterization of growth factor receptors and their signal transduction mechanisms, the role of oncogene expression in cellular differentiation, mechanisms of viral reproduction and oncogene activation, and DNA-protein interactions; and 3) developmental therapeutics, including characterization of tumor markers, isolation and characterization of tumor-associated antigens, development of monoclonal antibodies, development of antisense and triple helical-forming oligonucleotides to inhibit cancer cell growth, synthesis of novel antineoplastic agents, use of peripheral stem cells and cytokines in bone marrow transplantation, and design of protocols for improved drug delivery and pharmacokinetic analysis of anticancer agents. To achieve these specific aims we have assembled a group of 52 faculty with expertise in chemistry, biochemistry, cell biology, molecular biology, immunology, pathology, virology, pharmacology, toxicology, nutrition, and clinical oncology. In support of this research we have established core laboratory facilities in animal care, cell culture, histology, molecular biology including 2-dimensional gel electrophoresis, mass spectrometry, nuclear magnetic resonance spectrometry, computer services including molecular modeling and DNA and protein data base analysis, drug analysis and pharmacokinetics, microbial mutagenesis, glassware washing, and safety. In addition, we have established a Leukemia/Lymphoma Tissue Procurement Service that supports a region-wide program for data collection and protocol standardization. The Core Grant faculty also comprise the nucleus of our Cancer Biology Training Program for the education and research training of predoctoral and postdoctoral students.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA036727-11
Application #
2089154
Study Section
Cancer Center Support Review Committee (CCS)
Project Start
1984-07-01
Project End
1995-07-31
Budget Start
1994-09-01
Budget End
1995-07-31
Support Year
11
Fiscal Year
1994
Total Cost
Indirect Cost
Name
University of Nebraska Medical Center
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
City
Omaha
State
NE
Country
United States
Zip Code
68198
Chhonker, Yashpal S; Sleightholm, Richard L; Li, Jing et al. (2018) Simultaneous quantitation of hydroxychloroquine and its metabolites in mouse blood and tissues using LC-ESI-MS/MS: An application for pharmacokinetic studies. J Chromatogr B Analyt Technol Biomed Life Sci 1072:320-327
Lopez, Wilfredo; Page, Alexis M; Carlson, Darby J et al. (2018) Analysis of immune-related genes during Nora virus infection of Drosophila melanogaster using next generation sequencing. AIMS Microbiol 4:123-139
Iseka, Fany M; Goetz, Benjamin T; Mushtaq, Insha et al. (2018) Role of the EHD Family of Endocytic Recycling Regulators for TCR Recycling and T Cell Function. J Immunol 200:483-499
Barger, Carter J; Zhang, Wa; Sharma, Ashok et al. (2018) Expression of the POTE gene family in human ovarian cancer. Sci Rep 8:17136
Kumar, Vinod; Kumar, Virender; Chaudhary, Amit Kumar et al. (2018) Impact of miRNA-mRNA Profiling and Their Correlation on Medulloblastoma Tumorigenesis. Mol Ther Nucleic Acids 12:490-503
Huang, Yunlong; Li, Yuju; Zhang, Hainan et al. (2018) Zika virus propagation and release in human fetal astrocytes can be suppressed by neutral sphingomyelinase-2 inhibitor GW4869. Cell Discov 4:19
Baranovskiy, Andrey G; Siebler, Hollie M; Pavlov, Youri I et al. (2018) Iron-Sulfur Clusters in DNA Polymerases and Primases of Eukaryotes. Methods Enzymol 599:1-20
Fan, Wei; Zhang, Wenting; Alshehri, Sameer et al. (2018) Increasing time on target: utilization of inhibitors of cysteine cathepsins to enhance the tumor retention of receptor-targeted agents. Chem Commun (Camb) 54:11268-11271
Robb, Caroline M; Kour, Smit; Contreras, Jacob I et al. (2018) Characterization of CDK(5) inhibitor, 20-223 (aka CP668863) for colorectal cancer therapy. Oncotarget 9:5216-5232
Ouellette, Scot P; Messerli, Parker R; Wood, Nicholas A et al. (2018) Characterization of Chlamydial Rho and the Role of Rho-Mediated Transcriptional Polarity during Interferon Gamma-Mediated Tryptophan Limitation. Infect Immun 86:

Showing the most recent 10 out of 1372 publications